Tracheostomy Practices in Adult Intensive Care Units: A Multicentre Study in Izmir (IZ-TRACH)

February 5, 2026 updated by: Murat Kaykaç, Izmir City Hospital

TRACHEOSTOMY PRACTICES IN ADULT INTENSIVE CARE UNITS IN IZMIR, TURKEY: A MULTICENTRE POINT-PREVALENCE STUDY

The primary objective of this study was to determine the point prevalence of tracheostomy in adult intensive care units (ICUs) in Izmir and to evaluate indications, techniques, complications, timing, and short-term outcomes. This multicentre, descriptive point-prevalence study was conducted across seven adult ICUs on September 8, 2025. The study aimed to provide observational data on how tracheostomy is managed in a real-world clinical setting, focusing on the decision-making process and clinical characteristics associated with patient mortality

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This investigation was designed as a multicentre, descriptive point-prevalence study. On the specified prevalence day, all patients aged 18 years and older who had previously undergone tracheostomy using either surgical or percutaneous techniques in participating centers were included.

The data collection process involved:

  • Documentation of ICU structural characteristics, including bed capacity and annual tracheostomy volumes.
  • Systematic recording of patient demographics, comorbidities, tracheostomy indications, and the specific techniques used (e.g., Griggs guidewire dilating forceps, Ciaglia single-dilator, or surgical tracheostomy).
  • Assessment of early and post-procedural complications.
  • Evaluation of the time interval from endotracheal intubation to the tracheostomy procedure and identifying reasons for any delays.
  • A 30-day follow-up to assess mortality outcomes for all included patients.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients followed in seven different intensive care units in Izmir, Turkey, who required a tracheostomy for various clinical indications, primarily prolonged mechanical ventilation.

Description

Inclusion Criteria:

  • Patients aged 18 years and older
  • Hospitalized in the participating adult intensive care units on the point-prevalence day
  • Previously undergone tracheostomy using either surgical or percutaneous techniques

Exclusion Criteria:

  • Patients younger than 18 years
  • Patients without a tracheostomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Tracheostomy Patients
Adult patients (aged ≥18 years) hospitalized in intensive care units who have undergone either surgical or percutaneous tracheostomy.
Procedure: Tracheostomy
The application of surgical or percutaneous dilatational tracheostomy (Griggs guidewire dilating forceps or Ciaglia single-dilator techniques) for indications such as prolonged mechanical ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30-day mortality
Time Frame: 30 days post-procedure
The proportion of patients who died within 30 days following the tracheostomy procedure
30 days post-procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Izmir City Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2025

Primary Completion (Actual)

October 8, 2025

Study Completion (Actual)

October 8, 2025

Study Registration Dates

First Submitted

February 5, 2026

First Submitted That Met QC Criteria

February 5, 2026

First Posted (Actual)

February 11, 2026

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 5, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2025/352

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tracheostomy

Clinical Trials on Tracheostomy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe